Here's why these 4 ASX shares have surged higher today

The TPG Telecom Ltd (ASX:TPM) share price is one of four climbing significantly higher today. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 (Index: ^AXJO) (ASX: XJO) is on course to make it three days of declines in a row. In afternoon trade the benchmark index is down 0.5% to 5,807 points.

Not all shares have sunk lower today though. Four shares in particular have stood out with strong gains. Here's why they have jumped higher:

The Brambles Limited (ASX: BXB) share price is up 6% to $10.19 after the supply-chain logistics company released its third-quarter update. Brambles reported better-than-expected sales revenue from continuing operations of US$4,091.0 million for the first nine months of the financial year. This is a 5% increase on the prior corresponding period in constant currency terms.

The Fortescue Metals Group Limited (ASX: FMG) share price has climbed 3.5% to $5.27 despite the iron ore price sliding lower again overnight. According to Metal Bulletin the spot price for the benchmark 62% fines fell 4.6% to US$63.20 a tonne. This has extended iron ore's decline from its February high of US$94.86 a tonne to over 33%.

The TPG Telecom Ltd (ASX: TPM) share price has bounced back from yesterday's sharp decline with a 4.5% gain to $5.75. A research note out of UBS may have been the catalyst for today's jump. Its analysts upgraded the telco company to a buy rating with a $6.70 price target. I would have to agree with UBS on this one, TPG Telecom strikes me as a bargain at the current share price.

The Zelda Therapeutics Ltd (ASX: ZLD) share price has climbed 4% to 12.5 cents after the pot stock announced that it is extending its clinical trial in Chile. As well as insomnia and eczema, the company's clinical trial will now include autism. Management expects the clinical trial to commence in the second half of the year. If successful the company could be generating revenue in South America as soon as 2018.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »